BROWSE·page 502 of 605

Browse EX-10 agreements

7,253 matching material contract exhibits.


EX-10.1

CIENA CORP

[DEALER]

[_____], 2026

 

To:

Ciena Corporation 7035 Ridge Road

Hanover, MD 21076

Attention: The Treasury Department

Telephone No.: 410-694-5700

Email: List.Treasury@ciena.com

 

Re:

[Base][Additional] Call Option Transaction

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [_____] (“Dealer”) andCiena Corporation (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party further agrees that this Confirmation, together with the Agreement, evidence a complete binding agreement between Counterparty and Dealer as to the subject matter and terms of the Transaction to which this Confirmation relates, and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

…

EX-10.1·8-K·CIK 936395·ACC 0001193125-26-267607·Filed Jun 11, 2026, 16:21 ET

EX-10.2

CIENA CORP

[DEALER]

 

  

  

[_____], 2026

 

To:

Ciena Corporation

7035 Ridge Road

Hanover, MD 21076

 

Attention:

   The Treasury Department

 

Telephone

No.:  410-694-5700

 

Email:     

List.Treasury@ciena.com

 

Re:

[Base][Additional] Warrants

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Ciena Corporation (“Company”) to [_____] (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party further agrees that this Confirmation together with the Agreement evidence a complete binding agreement between Company and Dealer as to the subject matter and terms of the Transaction to which this Confirmation relates, and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

…

EX-10.2·8-K·CIK 936395·ACC 0001193125-26-267607·Filed Jun 11, 2026, 16:21 ET

EX-10.3

CIENA CORP

Execution Version

REFINANCING AMENDMENT

TO CREDIT AGREEMENT

REFINANCING AMENDMENT TO CREDIT AGREEMENT, dated as of June 11, 2026 (this “Amendment”), by and among Ciena Corporation, a Delaware corporation (the “Borrower”), the other Loan Parties party hereto, the 2026 Refinancing Revolving Lenders (as defined below), the L/C Issuers, the Swing Line Lender and Bank of America, N.A., as administrative agent (in such capacity, the “Administrative Agent”).

RECITALS:

…

EX-10.3·8-K·CIK 936395·ACC 0001193125-26-267607·Filed Jun 11, 2026, 16:21 ET

EX-10.1

Yext, Inc.

Document

Exhibit 10.1

YEXT, INC.

2016 EQUITY INCENTIVE PLAN

(as amended, restated and extended effective as of the 2026 Annual Meeting of Stockholders)

1.    Purposes of the Plan. The purposes of this Plan are:

•to attract and retain the best available personnel for positions of substantial responsibility,

•to provide additional incentive to Employees, Directors and Consultants, and

•to promote the success of the Company’s business.

The Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units and Performance Shares.

2.    Definitions. As used herein, the following definitions will apply:

(a)    “Administrator” means the Board or any of its Committees as will be administering the Plan, in accordance with Section 4 of the Plan.

(b)    “Affiliate” means any entity, other than a Subsidiary, in which the Company has an equity or other ownership interest.

…

EX-10.1·8-K·CIK 1614178·ACC 0001628280-26-042518·Filed Jun 11, 2026, 16:17 ET

EX-10.1

BERKLEY W R CORP

Document

FIRST AMENDMENT TO CREDIT AGREEMENT

This FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of June 9, 2026 (this “Amendment”), among W. R. BERKLEY CORPORATION, a Delaware corporation (the “Borrower”), each lender party to the Credit Agreement referred to below (collectively, the “Lenders”), and BANK OF AMERICA, N.A., as Administrative Agent (the “Administrative Agent”) and the Swing Line Lender. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Credit Agreement referred to below.

WHEREAS, the Borrower, the Lenders, and the Administrative Agent are party to that certain Credit Agreement, entered into as of April 1, 2022 (as amended, restated, amended and restated, supplemented or otherwise modified and in effect from time to time, the “Credit Agreement”).

…

EX-10.1·8-K·CIK 11544·ACC 0000011544-26-000020·Filed Jun 11, 2026, 16:17 ET

EX-10.01

Alphabet Inc.

ALPHABET INC. AMENDED AND RESTATED 2021 STOCK PLAN

 

Purpose of the Plan

This Plan is intended to promote the interests of the Company and its stockholders by providing the employees and consultants of the Company and members of the Board of Directors with incentives and rewards to encourage them to continue in the service of the Company and with a proprietary interest in pursuing the long-term growth, profitability and financial success of the Company.

 

Definitions

As used in the Plan or in any instrument governing the terms of any Incentive Award, the following definitions apply to the terms indicated below:

 

 

(a)

“Alphabet” means Alphabet Inc., a Delaware corporation.

 

 

(b)

…

EX-10.01·8-K·CIK 1652044·ACC 0001193125-26-267578·Filed Jun 11, 2026, 16:17 ET

EX-10.2

AIM ImmunoTech Inc.

PLACEMENT AGENCY AGREEMENT

June 9, 2026

 

Ladenburg Thalmann & Co. Inc.

999 Vanderbilt Beach Road, Suite 200

Naples, Florida 34105

 

Ladies and Gentlemen:

 

Introduction. Subject to the terms and conditions herein (this “Agreement”), AIM ImmunoTech, Inc., a Delaware corporation (the “Company”), hereby agrees to sell (A) up to 2,554,119 registered shares (the “Registered Shares”) of common stock, par value $0.001 per share (“Common Stock”), (B) up to 771,503 unregistered shares (the “Unregistered Shares”, and together with the Registered Shares, the “Shares”) of Common Stock, (C), at the election of the Investor, in lieu of the Registered Stock, up to 1,782,616 unregistered pre-funded warrants to purchase 1,782,616 shares of Common Stock (the “Pre-Funded Warrants”); and (D) Class J Common Stock purchase warrants (the “Warrants”) to purchase up to an aggregate of 10,216,476 shares of Common Stock. Each Pre-Funded Warrant will be exercisable upon issuance and will expire when exercised in full. The Warrant will be exercisable on the date of receipt of shareholder approv

…

EX-10.2·8-K·CIK 946644·ACC 0001493152-26-028283·Filed Jun 11, 2026, 16:15 ET

EX-10.1

AIM ImmunoTech Inc.

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of June 9, 2026, between AIM ImmunoTech, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”) as to the Registered Shares, and (ii) an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder as to the Pre-Funded Warrants, the Pre-Funded Warrant Shares, the Unregistered Shares, the Common Warrants and the Common Warrant Shares, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

…

EX-10.1·8-K·CIK 946644·ACC 0001493152-26-028283·Filed Jun 11, 2026, 16:15 ET

EX-10.2

BeOne Medicines Ltd.

Document

Exhibit 10.2

BEONE MEDICINES LTD.

SIXTH AMENDED AND RESTATED 2018 EMPLOYEE SHARE PURCHASE PLAN

The purpose of the BeOne Medicines Ltd. Sixth Amended and Restated 2018 Employee Share Purchase Plan (the “Plan”) is to provide the Participants (as defined in Section 1) with opportunities to purchase Shares (either in the form of Ordinary Shares or ADSs).

The Plan includes two components: a Code Section 423 component (the “423 Component”) and a non-Code Section 423 component (the “Non-423 Component”). The 423 Component is intended to constitute an “employee stock purchase plan” within the meaning of Section 423(b) of the United States Internal Revenue Code of 1986, as amended (the “Code”), and the 423 Component shall be interpreted in accordance with that intent. Under the Non-423 Component, which does not qualify as an “employee stock purchase plan” within the meaning of Section 423(b) of the Code, Options may be granted pursuant to any rules, procedures, agreements, appendices or sub-plans adopted by the Administrator in offering the Plan to eligible employees participatin

…

EX-10.2·8-K·CIK 1651308·ACC 0001651308-26-000017·Filed Jun 11, 2026, 16:13 ET

EX-10.1

BeOne Medicines Ltd.

Document

Exhibit 10.1

BEONE MEDICINES LTD.

FIFTH AMENDED AND RESTATED 2016 SHARE OPTION AND INCENTIVE PLAN

 

SECTION 1.      GENERAL PURPOSE OF THE PLAN; DEFINITIONS

 

The name of the plan is the BeOne Medicines Ltd. Fifth Amended and Restated 2016 Share Option and Incentive Plan (the “Plan”). The purpose of the Plan is to encourage and enable the officers, employees, Non-Employee Directors and Consultants of BeOne Medicines Ltd. (the “Company”) and its Subsidiaries (together with the Company, the “Group”) upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its businesses to acquire a proprietary interest in the Company. It is anticipated that providing such persons with a direct stake in the Company will assure a closer identification of their interests with those of the Company and its shareholders, thereby stimulating their efforts on the Company’s behalf and strengthening their desire to remain with the Company.

The following terms shall be defined as set forth below:

…

EX-10.1·8-K·CIK 1651308·ACC 0001651308-26-000017·Filed Jun 11, 2026, 16:13 ET

EX-10.1

Bally's Corp

Document

5 June 2026

BALLY’S INTRALOT S.A.

(as Bidco)

and

BALLY’S INTRALOT JERSEY SECURITIES LIMITED

(as JerseyCo)

and

EVOKE PLC

(as Target)

COOPERATION AGREEMENT

related to the proposed acquisition of

EVOKE PLC

99 Bishopsgate London EC2M 3XF United Kingdom Tel: +44.20.7710.1000

www.lw.com


CONTENTS

Clause

Page

DEFINITIONS AND INTERPRETATION

1

PUBLICATION OF THE ANNOUNCEMENT AND THE TERMS OF THE PROPOSED ACQUISITION

10

APPLICATION OF THE CODE

10

CODE COMMITTEE MATTERS

12

REGULATORY CLEARANCES

16

BIDCO DOCUMENTS, SHARES AND BOARD RECOMMENDATION

20

SCHEME DOCUMENT

21

IMPLEMENTATION OF THE PROPOSED ACQUISITION

23

SWITCHING TO A TAKEOVER OFFER

…

EX-10.1·8-K·CIK 1747079·ACC 0001747079-26-000073·Filed Jun 11, 2026, 16:13 ET

EX-10.1

Alphatec Holdings, Inc.

ALPHATEC HOLDINGS, INC.

2026 EQUITY INCENTIVE PLAN

ARTICLE I Purpose

 

The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. Capitalized terms used in the Plan are defined in Article XI.

ARTICLE II Eligibility

 

Service Providers are eligible to be granted Awards under the Plan, subject to the limitations described herein.

ARTICLE III Administration and Delegation

…

EX-10.1·8-K·CIK 1350653·ACC 0001193125-26-267552·Filed Jun 11, 2026, 16:13 ET